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The incidence of obesity and overweight has reached epidemic proportions in the developed world as well as in those countries
transitioning to ﬁrst world economies, and this represents a major global health problem. Concern is rising over the rapid
increases in childhood obesity and metabolic disease that will translate into later adult obesity. Although an obesogenic nutritional
environment and increasingly sedentary lifestyle contribute to our risk of developing obesity, a growing body of evidence links
early life nutritional adversity to the development of long-term metabolic disorders. In particular, the increasing prevalence of
maternal obesity and excess maternal weight gain has been associated with a heightened risk of obesity development in oﬀspring
in addition to an increased risk of pregnancy-related complications. The mechanisms that link maternal obesity to obesity in
oﬀspring and the level of gene-environment interactions are not well understood, but the early life environment may represent a
critical window for which intervention strategies could be developed to curb the current obesity epidemic. This paper will discuss
the various animal models of maternal overnutrition and their importance in our understanding of the mechanisms underlying
altered obesity risk in oﬀspring.
1.Background
The current epidemic of obesity and related metabolic
disorders has been seen as a symptom of aﬄuence with the
primary cause relating to the development of an obesogenic
environment and ease of access to highly caloriﬁc foods and
reducedenergyexpenditureinworkandleisureactivities[1].
The metabolic syndrome is characterised by the clustering
of cardiovascular risk factors including diabetes, obesity,
hyperlipidaemia, and hypertension and is likely the result of
complex interactions between genes, dietary intake, physical
activity, and the environment. Within the cluster of risk
traits for the metabolic syndrome, insulin resistance and
visceral obesity have been recognized as the most important
causal factors [2]. A number of genes have been identiﬁed
that are associated with obesity and metabolic syndrome in
humans [1, 3], but the genetic component of this condition
cannot account for the marked increases in the prevalence
of obesity and metabolic syndrome in recent years. In this
context, the developmental origins of health and disease
(DOHaD) hypothesis has highlighted the link between the
periconceptual, fetal, and early infant phases of life and
subsequent development of adult obesity and the metabolic
syndrome [4–6].
The mechanisms underpinning the developmental pro-
gramming framework and the role of genetic versus environ-
mental factors remain speculative. One general thesis is that
in response to an adverse intrauterine environment the fetus
adapts its physiological development to maximize its imme-
diate chances for survival. These adaptations may include
resetting metabolic homeostasis set points, endocrine sys-
tems, and downregulating of growth, commonly manifest
in an altered birth phenotype. More recently the “predictive
adaptive response” (PARs) hypothesis proposes that the
degree of mismatch between the pre- and postnatal envi-
ronments is a major determinant of subsequent disease risk
[7, 8]. Thus, it is thought that whilst adaptive changes in fetal
physiology may be beneﬁcial for short-term survival in utero,
they may be maladaptive in later life, contributing to adverse
health outcomes when oﬀspring are exposed to catch-up
growth, diet-induced obesity, and other factors [8, 9].
Animal models have been extensively used to study
the basic physiological principles underlying the DOHaD
hypothesis and are essential to the search for the mechanistic2 Experimental Diabetes Research
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Figure 1: Basic schematic outlining consequences of a maternal obesogenic environment on the health and well-being of oﬀspring. These
eﬀects can be modiﬁed by the timing and duration of exposure to the obesogenic environment as well as gender and composition of the HF
diet (e.g., fat source). Programming eﬀects can be further exacerbated in the presence of a suboptimal postweaning nutritional environment.
links between prenatal and postnatal inﬂuences and risk
for developing the metabolic syndrome in later life. Epi-
demiological data suggest that developmental programming
occurs within the normal range of birth size [10, 11],
but most early experimental work has focused on fetal
growth restriction in the assumption that insults impairing
fetal growth are likely to be those triggering developmental
programming. However, over recent years there has been an
increasing focus on developing models of maternal obesity.
Obesity in pregnancy and gestational diabetes represent a
special problem, not only as a result of their immediate
adverse eﬀects on maternal health and pregnancy outcome,
but also because of growing evidence for their persistent
and deleterious eﬀects on the developing oﬀspring [12].
However, in obese women, it is diﬃcult to discern between
genetic and environmental contributions in oﬀspring disease
risk.Severalobesogenicanimalmodels,primarilyperformed
in the rodent, show a relatively common phenotype of
metabolicdisordersinoﬀspring,butthemagnitudeofeﬀects
diﬀers with the timing of the nutritional challenge and diet
composition [13]. A recent systematic review by Ainge et al.
showedthatalthoughamaternalHFdietwasassociatedwith
a real risk of type 2 diabetes and obesity in male oﬀspring,
inconsistencies between the studies limited an examination
of the mechanisms underlying phenotype development [14].
This paper will provide a current summary of animal models
of maternal obesity including model species, nature and
timing of dietary manipulations, phenotypic outcomes in
oﬀspring, possible mechanisms, and the potential role of
epigenetics.
2. AnimalModels of MaternalObesity
2.1. Rodent Models. The rodent is the most commonly used
model species for investigation of developmental program-
ming via a maternal obesogenic nutritional environment.
A maternal cafeteria or high-fat (HF) diet has been shown
to induce obesity, insulin and leptin resistance [15–17],
hypertension [18–21], fatty pancreas disease [22], hepatic
steatosis, and nonalcoholic fatty liver disease in oﬀspring
[23–26]( Figure 1). It has also been reported that maternal
adiposity, and not dietary fat per se, induces hyperleptinemia
and insulin resistance in oﬀs p r i n g ,a sw e l la sa ni n c r e a s e d
body weight that persists into adulthood [27]. Even mild
maternal overnutrition has been shown to induce increased
adiposity, glucose intolerance, and altered brain appetiteExperimental Diabetes Research 3
regulators in oﬀspring [28]. Our own previous work has
shownthatamoderatematernalHFdietresultsinsigniﬁcant
obesity and hyperinsulinemia in male and female oﬀspring,
independent of the level of preconceptional obesity [29]
(Figure 2).
In general, two main approaches have been utilised,
a high-fat and/or high-sugar puriﬁed diet approach or a
“cafeteria diet” designed to mimic a complex western style
diet [17, 30, 31]. Both approaches have been extensively
utilised over recent years and have provided important
insights into disease development, particularly in relation
to the development of the metabolic syndrome. There has
been some recent debate as to which dietary approach
is more closely aligned to the human setting. A puriﬁed
HF diet normally utilises a modiﬁcation of a single fat
source, for example, lard, in order to induce excess weight
gain. Use of these puriﬁed “open source” diets has the
beneﬁt for targeted mechanistic studies in that manipulation
of a single dietary component can be easily undertaken
but has the downside that rodents are able to regulate
total caloric intake when fed a standard HF diet [32, 33].
A cafeteria diet, a mix of foods typiﬁed in the human
setting such as highly processed snack food, mimics a
more western style diet. However, interpretation of speciﬁc
macronutrient eﬀects is very diﬃcult due to the widely
varied macronutrient sources across the added foods and
the dietary interaction across the varied fat, protein, and
carbohydrate backgrounds. Further, there is some evidence
that speciﬁc components utilised in the cafeteria diet may
have deleterious eﬀects such as those related to dairy intake
in the rodent [34, 35] and oxidative stress [36]. Recent
work by Sampey et al. investigated the obesogenic and
inﬂammatory consequences of a cafeteria diet compared to
a lard-based 45% (of calories) HF diet in the rodent. Both
diets resulted in increased adiposity and hepatosteatosis but
cafeteria-fed rats displayed increased inﬂammation in white
fat, brown fat, and liver compared to HF and control groups
[37]. Interestingly, the review by Ainge et al. showed that
a maternal HF diet did confer an enhanced risk for T2DM
and obesity; however, poor glycaemic control across the
multiple studies examined appeared to be independent of
maternal obesity, birth weight, and level of postweaning diet
[14].
2.2. Sheep Models. Sheep models are less studied than the
rodent, but there is strong evidence from ovine models
that maternal obesity predisposes to altered growth and
metabolic sequelae in oﬀspring, data that closely parallels
that observed in the small animal models. In a study by
Zhang et al., an ovine model of maternal obesity was utilised
in which ewes were overfed in order to induce obesity
at conception and throughout gestation. At mid-gestation,
fetuses from obese ewes were macrosomic, hyperglycemic,
and hyperinsulinemic and exhibited markedly increased
pancreatic weight and β-cell numbers compared with fetuses
of ewes fed to requirements. These data also demonstrated
diﬀerential impacts of maternal obesity on fetal pancreatic
growth and β-cell numbers during early and late gestation.
During the ﬁrst half of gestation there was a marked increase
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Figure 2: Total body fat mass (%) as quantiﬁed by dual energy X-
ray absorptiometry (DEXA) in adult (day 150) male and female
rat oﬀspring of HF-fed mothers. CON = oﬀspring of control
pregnancies, MHF = oﬀspring of mothers fed an HF diet from
weaning and throughout pregnancy and lactation, PLHF mothers
fed a control diet until conception, and an HF diet throughout
pregnancy and lactation. Note that a preconceptional HF diet did
n o tc o n f e ra na l t e r e dr i s kf o ro b e s i t yd e v e l o p m e n to v e rt h a to fH F
exposure during pregnancy and lactation alone. Data are means ±
SEM, n = 10-11 per group, ∗P<0.05 versus CON. Modiﬁed from
Howie et al. [29].
in pancreatic growth, β-cell proliferation, and insulin secre-
tion, followed by a reduction in pancreatic growth and β-cell
numbers in late gestation, resulting in reduced circulating
insulin at term [38].
Maternal obesity and increased nutrient intake before
and during gestation in the ewe is known to result in
altered growth, adiposity, and glucose tolerance in adult
oﬀspring [39]. As with the rodent studies, diﬀerent levels
of overnutrition and weight gain during pregnancy have
diﬀerential eﬀects on fetal growth and organ development
[40]. Maternal overnutrition in late pregnancy results in an
upregulation of PPARγ-activated genes in fetal visceral fat
and a subsequent increase in the mass of subcutaneous fat
in the postnatal lamb. Exposure to maternal overnutrition
during the periconceptional period alone, however, was
shown to result in an increase in total body fat mass only in
female lambs with a dominant eﬀect on visceral fat depots.
Therefore, it was proposed that the early programming of
later obesity may result from “two hits”, the ﬁrst occurring
as a result of maternal overnutrition during the pericon-
ceptional period and the second occurring as a result of
increased fetal nutrition in late pregnancy [40].
In contrast to the rodent literature, where maternal
obesity has been shown to result in an ampliﬁed and
prolonged neonatal leptin surge [41], data in the sheep has
shown that maternal obesity eliminates the neonatal lamb
plasma leptin peak [39]. These diﬀerences may be explained
viatherelativeimmaturityoftheratatbirthcomparedtothe4 Experimental Diabetes Research
lamb,withthenewbornlambbeingbornatamoreadvanced
level of maturity equivalent to humans [39].
2.3. Nonhuman Primate. The extensive body of evidence in
small animal models and those undertaken in the sheep
linking a maternal HF diet to disease risk has been supported
by studies, albeit limited, in the nonhuman primate. One
of the earliest, in the baboon, showed that overfeeding in
the preweaning period permanently increased adiposity in
oﬀspring through fat cell hypertrophy, a gender-dependent
eﬀectinthefemalesonly[42].MaternalHFdiettriggerslipo-
toxicity in the fetal liver of macaques [43] and predisposes
the oﬀspring to develop nonalcoholic fatty liver disease in
adulthood. This aligns closely with work in the rodent where
a maternal high-fat diet has been shown to lead to “devel-
opmental priming” of hepatic steatosis in oﬀspring [24].
Data by Farley and colleagues demonstrated that for normal
weight oﬀspring of obese baboons, placental, and fetal
phenotypes were consistent with those described for large-
for-gestational age human fetuses [44]. Recent work in the
macaque by Grayson et al. showed that oﬀspring of mothers
fed an HF diet preconceptionally and throughout pregnancy
had smaller body weights in the early third trimester but
displayed catch-up growth and increased adiposity in the
postnatal period—the oﬀspring also developed early-onset
excess weight gain independent of postnatal diet [45]. A
primary ﬁnding of this work was the eﬀect of a maternal
HF diet on the oﬀspring’s melanocortin system. Third-
trimester fetuses from mothers on HF showed increases
in proopiomelanocortin mRNA expression, whereas agouti-
related protein mRNA and peptide levels were decreased in
comparison with control fetuses. In this study, a subgroup
of adult HF animals was switched to a control diet during
pregnancy (diet reversal). Although at the time of concep-
tion the diet reversal animals remained signiﬁcantly obese
and insulin resistant compared to controls, the oﬀspring
displayed normal melanocortin levels. These data suggest
that chronic consumption of an HF diet during pregnancy,
independent of maternal obesity and diabetes, can lead to
widespread activation of proinﬂammatory cytokines that
may alter the development of the melanocortin system. This
aligns with the work in the rat by Howie et al., whereby
preconceptional maternal obesity did not impact on obesity
in oﬀspring above that induced by an HF diet during
pregnancy and lactation alone [29]. It has also recently
been shown that chronic consumption of an HF diet during
pregnancy causes perturbations in the serotonergic system
and increased anxiety-like behavior in nonhuman primate
oﬀspring [46].
In the Japanese macaque, consumption of an HF diet,
independent of maternal obesity, increased placental inﬂam-
matory cytokines and the expression of Toll-like receptor 4
[47]. HF diet consumption also reduced volume blood ﬂow
on the fetal side of the placenta and signiﬁcantly increased
the frequency of both placental infarctions and stillbirth.
These results suggest that an HF diet, independent of
obesity, decreases uterine volume blood ﬂow with maternal
obesity and insulin resistance further exacerbating placental
dysfunction and resulting in an increased frequency of still-
birth [47]. This aligns with the rodent data whereby a ma-
ternal HF diet has been shown to result in reduced fetal and
placental junctional zone weights [48].
3.Mechanisms
The mechanisms underpinning maternal obesity and pro-
gramming of obesity risk in oﬀspring are not well deﬁned.
Limited data to date highlight the role of altered leptin
production and regulation and changes in the hypothalamic
regulation of key genes involved in appetite control and
energy balance. There is also evidence of altered skeletal
muscle metabolism and maternal HF diet-induced eﬀects on
placental structure and function.
3.1. Leptin and the Regulation of Energy Balance. One of the
most studied and consistent observations is hyperphagia and
altered energy intake [49]. Early data suggested a change
in food preference with maternal HF oﬀspring displaying a
preference for junk food over chow [50] and more recent
studies demonstrate hyperphagia in chow-fed oﬀspring of
obese mothers [41, 51]. Programmed resistance to the
adipokine leptin is as a prime candidate for the mechanism
predisposing towards an altered energy balance. The leptin
surge has been well characterised in the rodent; it appears to
be neonatal in origin and is associated with an upregulation
in leptin mRNA expression in adipose tissue over the same
time course [41, 52]. Maternal obesity has been shown to
result in an ampliﬁed and prolonged leptin surge in neonatal
rat oﬀspring [41]. In the rat, the leptin surge is seen as
a consequence of elevated maternal serum leptin during
the early postnatal period leading to elevated milk leptin
concentrations and hyperleptinemia in suckling oﬀspring.
However, there are some inconsistencies across studies—
milk from HF dams has been shown to have signiﬁcantly
higher fat content compared to controls associated with
increased insulin but not leptin concentrations [53]. It must
be noted, however, that although the leptin surge in the
rodent has been well described, the precise timing and
characteristics of the neonatal leptin peak have not been well
deﬁnedinoﬀspring ofeithernormalorobesemothersinany
precocial species. Further studies have described lactational
failure and increased neonatal mortality in oﬀspring of HF
fed mothers [54]. It has also recently been reported that
obese mothers spend signiﬁcantly more time nursing their
young which could manifest as programming changes in the
HPA via altered maternal care as described by Meaney and
colleagues [55, 56].
3.2. Hypothalamic Reprogramming. Despite the increasing
evidence for a neurotropic role of leptin in the rodent, the
potentialroleinhumansandthetimingofthepossibleleptin
surge is less deﬁned. Kirk et al. have shown that maternal
diet-induced obesity permanently inﬂuences central pro-
cessesregulatingfoodintakeinoﬀspringviaprogrammingof
leptin resistance and altered hypothalamic functions involv-
ing the arcuate nucleus and paraventricular nucleus. Further,
intrauterine and early postnatal overnutrition programmes
hypothalamic neurons expressing the appetite stimulatorExperimental Diabetes Research 5
neuropeptide Y (NPY) and suppressor proopiomelanocortin
(POMC) in oﬀspring at weaning [15]. However, the long-
term eﬀects of such programming and its interactions with
postweaning HF diet consumption remain unclear. Several
studies have highlighted alterations in peroxisome prolifera-
tor activated receptor (PPAR) gene expression in oﬀspring of
obese mothers, which may contribute to the disturbed lipid
homeostasis. HF oﬀspring have decreased hepatic PPARγ
expression compared with controls and reduced hepatic
PPARα expression which negatively correlated with serum
triglyceride levels [57].
3.3. Skeletal Muscle and Locomotor Activity. Work by Simar
et al. in the adult rat revealed an interaction between
maternal obesity and postnatal overnutrition on skeletal
muscle metabolism, a postweaning HF diet exerted an
additive eﬀect to that of maternal obesity on body weight
and skeletal muscle markers of glucose and lipid metabolism
but not on plasma glucose and insulin levels, suggesting that
maternal obesity and postnatal overnutrition impair skeletal
muscle function via diﬀerent mechanisms [58]. Reduced
muscle mass has also been reported in 3- and 6-month-
old male and female oﬀspring from obese mice [31]a n d
reduced muscle force in oﬀspring of mothers fed a junk food
diet [59]. Work in the sheep matches closely that reported
for the rat; lambs born to obese mothers have impaired
insulin signalling in muscle compared with control lambs
which correlated with increased intramuscular triglycerides
and higher expression of fatty acid transporters and PPAR-γ
[60].
Although several studies have examined changes in
locomotor activity in the setting of maternal undernutrition
[61–63], data on energy expenditure and physical activity
in models of maternal obesity have yet to be undertaken
despite the numerous studies that have observed diﬀerences
in muscle development in oﬀspring of obese mothers.
3.4. Placental Function. Altered placental function in the
setting of maternal obesity has also been the focus of several
investigations. Our group and others have reported altered
placental structure and function as a result of a maternal
HF diet across a range of experimental models. In the
pregnant rat, a maternal HF diet has been shown to reduce
growth of the fetus and the placental junctional zone, but
not placental labyrinth zone growth [48]. In the pregnant
sheep, maternal obesity markedly increases placental fatty
acid transporter expression and inﬂammatory signalling
pathways and enhances cytokine expression in mid-gestation
[57]. Similarly, maternal obesity in the baboon is associated
with a maternal inﬂammatory state and induces structural
and functional changes in the placenta [44].
3.5. Interventions. Until relatively recently, developmental
programming was seen as an irreversible change in devel-
opmental trajectory. Outside of the early taurine reversal
work in the setting of the maternal low protein model
[64], there is a paucity of data on intervention strate-
gies whether it be nutritional or targeted pharmacologic
approaches. It has recently been shown that interventions
with leptin, folic acid, and exendin-4 in the early phases
of developmental plasticity can ameliorate or reverse some
of the eﬀects associated with developmental programming
[65–67]. However, these agents were examined in the
context of maternal nutritional deprivation and have not
been studied in the setting of maternal overnutrition,
despite the commonality of oﬀspring phenotypes across the
disparate nutritional models. Similarly, exercise has been
shown to have beneﬁcial eﬀects in obesity-prone oﬀspring
of undernourished mothers [62, 68] ,b u tn os t u d i e st od a t e
have examined exercise interventions in oﬀspring of HF-fed
mothers.
There is evidence for a role of diet reversal in ame-
liorating the eﬀects of maternal obesity on oﬀspring out-
come. In the nonhuman primate, diet reversal from an
HF to control diet during pregnancy led to normalisation
of the melanocortin levels, improvements in fetal hepatic
triglycerides, and partial normalization of the expression
of gluconeogenic enzymes. These results suggested that
simply changing to a normal low-fat diet, speciﬁcally during
pregnancy, can lower, but not eliminate, the risk for fetal
hepatic steatosis [43]. Similar results have been shown in the
rat whereby dietary intervention prior to pregnancy reversed
metabolic programming in male oﬀspring of obese rats [69].
4. Role of Epigenetics
Epigenetic processes lead to heritable changes in gene func-
tionbyalteringDNAchemistryindependentofsequenceand
may be responsible for tissue-speciﬁc gene expression during
diﬀerentiation. Epigenetic modiﬁcations may be one mech-
anism by which exposure to an altered intrauterine milieu
or metabolic perturbation may inﬂuence the phenotype of
the organism much later in life [70]. However, how the four
epigenetic modalities—DNA methylation, non-coding RNA,
transcriptionfactors,andhistonemodiﬁcations—contribute
to epigenetic memory and how epigenomic changes may
mediate the altered control of fetal gene expression as a
consequence of maternal obesity are not well characterised.
Experimental data in rodents and recent observations in
humans suggest that epigenetic changes in regulatory and
growth-related genes play a signiﬁcant role in mediating the
pathophysiological phenotypes derived from developmental
programming [71, 72]. Histone modiﬁcations in conjunc-
tion with DNA methylation regulate chromatin structure
and gene expression. However, it is still debated where
early life and/or environmental factors can inﬂuence the
“histone”codeinamannersimilartotheirinﬂuenceonDNA
methylation [73].
Adversity during pregnancy or early neonatal life in
experimental programming models results in changes in
promoter methylation, therefore, directly or indirectly, aﬀect
gene expression in pathways associated with a range of phys-
iologic processes [74]. For example, in the rat, altered pro-
moter methylation and downstream changes in gene expres-
sion have been shown for the hepatic glucocorticoid receptor
(GR) and PPAR-α [66, 75], inﬂuencing carbohydrate and
lipid metabolism. The phenotypic eﬀects of epigenetic mod-
iﬁcations during development may not manifest until later6 Experimental Diabetes Research
in life, especially if they aﬀect genes modulating responses
to later environmental challenges, such as dietary challenges
with an HF diet. The timing of the developmental windows
and the induction of epigenetic changes in key physiologic
systems is not well characterised, but it appears to extend
from the periconceptional period [76] into postnatal life [77,
78]. Many of the genes regulated by epigenetic change do not
appeartobeclassicallyimprinted(expressedaccordingtothe
parental origin of the allele), although some imprinted genes
may show altered expression after perturbations during
early development, such as if blastocyst culture in vitro is
prolonged [79].
It has been shown that the promoter in the leptin
gene is subject to epigenetic programming, and leptin gene
expression can be modulated by DNA methylation [80–82].
Recent studies report that impaired glucose tolerance during
pregnancy is associated with adaptations in leptin gene DNA
methylation although the functional signiﬁcance of these
c h a n g e si sn o ty e tc l e a r[ 83]. Yokomori et al. demonstrated
that methylation of speciﬁc CpG sites and a methylation-
sensitive protein could contribute to changes in leptin gene
expression during adipocyte diﬀerentiation in 3T3-L1 cells
[84].Inaddition,diﬀerentialDNAmethylationwasobserved
in promoters of genes involved in glucose metabolism
including GLUT4 [85] and uncoupling protein (UCP)-2
[86], both major contributors to the development of T2DM.
Developmental epigenetics is believed to establish “adap-
tive phenotypes” to meet the demands of the later-life envi-
ronment [73, 87]. Implicit in this concept is an important
process of causality on the cellular level, regulating growth
and tissue diﬀerentiation and involving chemical changes
to the DNA or associated proteins. Once the mechanistic
basis of the disease is understood, epigenetic processes
are potentially reversible and intervention and strategies
aimed at reversal could be devised and implemented. A
recent study suggested that a substantial component of
metabolic disease risk has a prenatal developmental basis
and that perinatal epigenetic analysis may have utility in
identifying individual vulnerability to later obesity and
metabolic disease [88]. In this study, they reported a link
between gene promoter methylation of retinoid x-receptor
alpha (RXRA) in umbilical cord tissue and later risk of
childhood adiposity.
5. PaternalTransmission
There is now evidence supporting a role for paternal trans-
mission of disease risk across generations. Ng et al. recently
reported that a paternal high-fat diet can program β-cell
“ d y s f u n c t i o n ”i nr a tF 1f e m a l eo ﬀspring. Paternal HF diet
altered the expression of 642 pancreatic islet genes in adult
female oﬀspring including functional gene clusters related
to cation and ATP binding, cytoskeleton, and intracellular
transport. Broader pathway analysis demonstrated involve-
ment of calcium-, MAPK-, and Wnt-signalling pathways,
apoptosis, and cell cycle regulation. Hypomethylation of
the Il13ra2 gene, which showed the highest fold diﬀerence
in expression, was demonstrated. This work provided the
ﬁrst evidence in mammals of nongenetic, intergenerational
transmission of metabolic sequelae of an HFD from father
to oﬀspring [89]. Yazbek et al. also provided evidence for
paternaltransgenerationalgeneticeﬀectsonbodyweightand
food intake. Utilising the obesity-resistant 6C2d congenic
strain, which carries the Obrq2aA/J allele on an otherwise
C57BL/6J background, obesity-resistant and hypophagic
phenotypes were transmitted through the paternal lineage
but not the maternal lineage with equal strength for at least
two generations [90]. Of note, a recent study has shown that
a maternal HF diet has eﬀects on third-generation female
bodysizeviathepaternallineage[91]whichsupportsastable
germline-based transgenerational mode of inheritance. The
extent of the contribution of obese fathers on oﬀspring phe-
notype development is now an increasing area of research,
particularly as regards the role of nongenetic factors in the
causal pathway.
6. Summary
Animal studies across a range of species and varied
obesogenic diets have provided clear evidence linking
maternal obesity and increased risk for obesity in oﬀ-
spring and are invaluable tools in the investigation of
mechanisms underpinning this linkage. Given the cur-
rent obesity epidemic and the increasing number of
obese women entering pregnancy, there is an urgent need
for interventional strategies that target developmentally
programmed obesity. The evidence available on short-
and long-term health impact for mother and child cur-
rently favours actions directed at controlling prepregnancy
weight and preventing obesity in females of reproductive
ages [92] although more trials are needed to evaluate
the eﬀects of nutritional and behavioural interventions in
pregnancy outcomes. Moreover, suggestions that maternal
obesity may transfer obesity risk to child through non-
Mendelian (e.g., epigenetic) mechanisms require more long-
term investigation. Of note, evidence for the programming
of obesity and several other features of the metabolic
syndrome have been observed under both nutrient restric-
tion (caloric, protein, iron) and overnutrition studies, possi-
blysuggestiveofacommonalityofmechanism.Theperinatal
environment provides a potential therapeutic target, and
focusing on this speciﬁc developmental stage may translate
into improved interventional strategies to stem the growing
epidemic of obesity. Failure to recognize that maternal
diet and maternal obesity play a critical role in develop-
mental programming of adult disease may ultimately accel-
erate the obesity epidemic through successive generations,
independent of further genetic or environmental factors.
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